Literature DB >> 10643625

Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.

M Pinzani1, P Gentilini.   

Abstract

In the past 10 years we have witnessed an exponential increase in the knowledge on the development and progression of liver fibrosis. At present, liver fibrogenesis is referred to as a dynamic process involving complex cellular and molecular mechanisms, resulting from the chronic activation of the tissue repair mechanisms that follows reiterated liver tissue injury. The identification and characterization of the cell types and of the different mediators involved in this process has allowed a "revisitation" of several issues related to liver cirrhosis and its immediate consequences. Among these, evaluation of the relationships occurring between fibrogenesis and portal hypertension, cholestasis, and the development of hepatocellular carcinoma represent some of the hottest areas of research in the field of hepatology. Our aim is to establish a link between the available knowledge on the biology of hepatic stellate cells and their possible implication in the genesis and progression of portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10643625     DOI: 10.1055/s-2007-1007128

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  23 in total

1.  Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.

Authors:  Y Yang; E M Nemoto; S A K Harvey; V M Subbotin; C R Gandhi
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 2.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

Review 3.  Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.

Authors:  Ahmed A Magan; Atif A Khalil; Mohamed H Ahmed
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

4.  Predicting portal hypertension as assessed by acoustic radiation force impulse: correlations with the Doppler ultrasound.

Authors:  J-Y Han; J H Cho; H J Kwon; K J Nam
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

Review 5.  New cellular and molecular targets for the treatment of portal hypertension.

Authors:  Jordi Gracia-Sancho; Raquel Maeso-Díaz; Anabel Fernández-Iglesias; María Navarro-Zornoza; Jaime Bosch
Journal:  Hepatol Int       Date:  2015-03-05       Impact factor: 6.047

6.  Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells.

Authors:  E Novo; F Marra; E Zamara; L Valfrè di Bonzo; A Caligiuri; S Cannito; C Antonaci; S Colombatto; M Pinzani; M Parola
Journal:  Gut       Date:  2005-07-24       Impact factor: 23.059

7.  Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells.

Authors:  Izabel C Souza; Leo Anderson M Martins; Barbara P Coelho; Ivana Grivicich; Regina M Guaragna; Carmem Gottfried; Radovan Borojevic; Fátima Costa Rodrigues Guma
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

8.  Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.

Authors:  Yin-Ying Lu; Chun-Ping Wang; Lin Zhou; Yan Chen; Shu-Hui Su; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

10.  Endothelin and vascular function in liver disease.

Authors:  K Moore
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.